Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erdheim-Chester Disease”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT02608619
What this trial is testing

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

Who this might be right for
Erdheim-Chester DiseaseLangerhans Cell HistiocytosisHistiocytic Disorders
Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Looking for participantsNCT06712810
What this trial is testing

Q702 for the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic 46
Not applicableLooking for participantsNCT02285582
What this trial is testing

International Rare Histiocytic Disorders Registry (IRHDR)

Who this might be right for
Rare Histiocytic Disorders (RHDs)Erdheim-Chester Disease (ECD)Rosai-Dorfman Disease (RDD)+7 more
The Hospital for Sick Children 400
Not applicableUnknownNCT02089724
What this trial is testing

Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease

Who this might be right for
Erdheim-Chester Disease
Groupe Hospitalier Pitie-Salpetriere 20
Large-scale testing (Phase 3)Looking for participantsNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more
Cancer Research UK 30
Not applicableWithdrawnNCT02298634
What this trial is testing

Biomarker for Farber Disease (BioFarber)

Who this might be right for
Farber's LipogranulomatosisCeramidase DeficiencyHepatomegaly+1 more
CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Study completedNCT02281760
What this trial is testing

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

Who this might be right for
BRAF V600E Mutation
National Human Genome Research Institute (NHGRI) 9
Testing effectiveness (Phase 2)WithdrawnNCT03794297
What this trial is testing

Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations

Who this might be right for
Erdheim-Chester Disease
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT03990428
What this trial is testing

Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases

Who this might be right for
Supportive Care Needs of Caregivers
Memorial Sloan Kettering Cancer Center 250
Testing effectiveness (Phase 2)Looking for participantsNCT04079179
What this trial is testing

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Who this might be right for
Langerhan's Cell HistiocytosisJuvenile XanthogranulomaErdheim-Chester Disease+4 more
Carl Allen 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT02523040
What this trial is testing

Lenalidomide for Adult Histiocyte Disorders

Who this might be right for
Langerhans Cell Histiocytosis (LCH)Histiocytoses Erdheim-chester DiseaseHistiocytic Sarcoma (HS)
Dana-Farber Cancer Institute 12
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)UnknownNCT05092815
What this trial is testing

The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation

Who this might be right for
Langerhans Cell HistiocytosisErdheim-Chester DiseaseLCH+1 more
Shanghai Henlius Biotech 25
Not applicableUnknownNCT06317246
What this trial is testing

Subtypes and Prognostic Factors in Erdheim-Chester Disease

Who this might be right for
Erdheim-Chester Disease
Meyer Children's Hospital IRCCS 70
Large-scale testing (Phase 3)Looking for participantsNCT05768178
What this trial is testing

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Who this might be right for
Haematological MalignancyMelanomaThyroid Cancer, Papillary+9 more
Cancer Research UK 30
Not applicableLooking for participantsNCT07454343
What this trial is testing

ECD-Score: a Study on Erdheim-Chester Disease

Who this might be right for
Erdheim-Chester Disease (ECD)
Meyer Children's Hospital IRCCS 1,000
Not applicableLooking for participantsNCT05915208
What this trial is testing

Histiocytic Disorder Follow-up Study

Who this might be right for
HistiocytosisLangerhans Cell HistiocytosisErdheim-Chester Disease+3 more
University of Alabama at Birmingham 6,000
Not applicableUnknownNCT06332183
What this trial is testing

GWAS and EWAS in Patients With Erdheim-Chester Disease

Who this might be right for
Erdheim-Chester Disease
Augusto Vaglio 300
Not applicableStudy completedNCT01417520
What this trial is testing

Clinical and Pathophysiological Investigations Into Erdheim Chester Disease

Who this might be right for
MyelofibrosisGaucher DiseasePulmonary Fibrosis+2 more
National Human Genome Research Institute (NHGRI) 88
Not applicableStudy completedNCT03233841
What this trial is testing

Farber Disease Natural History Study

Who this might be right for
Farber DiseaseFarber's DiseaseFarber Lipogranulomatosis+4 more
Sumitomo Pharma Switzerland GmbH 45
Next Page